Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 7, 2009, Pages 724-728

  Quigley, Jeffrey E ^a   Elmarakby, Ahmed A ^a   Knight, Sarah F ^a   Manhiani, Marlina M ^a   Stepp, David W ^a   Olearzcyk, Jeffrey J ^a   Imig, John D ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Db db mice; Hypertension; Inflammation; Obesity; Oxidative stress

Indexed keywords

8 ISOPROSTANE; ALBUMIN; CHLORDANE; COLLAGEN TYPE 4; DEOXYCORTICOSTERONE ACETATE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID BLOOD LEVEL; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMPLANTATION; INFLAMMATION; KIDNEY INJURY; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; URINARY EXCRETION;

ANIMALS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; HYPERTENSION; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; OXIDATIVE STRESS; POTASSIUM, DIETARY; SODIUM CHLORIDE, DIETARY;

EID: 67650751654     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05139.x     Document Type: Article

References (24)

1. Caballero BL. The global epidemic of obesity. An overview. Epidemiol. Rev. 2007 29 : 1 5.
2. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 42 : 1206 52.
3. Lastra G, Manrique C, McFarlane SI, Sowers JR. Cardiometabolic syndrome and chronic kidney disease. Curr. Diab. Rep. 2006 6 : 207 12.
4. Locatelli F, Pozzoni P, Del Vecchio L. Renal manifestations in the metabolic syndrome. J. Am. Soc. Nephrol. 2006 17 (Suppl. S81 5.
5. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004 291 : 844 50.
6. Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes. Res. 1998 6 : 97 106. (Pubitemid 128679649)
7. Elmarakby AA, Quigley JE, Pollock DM, Imig JD. Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 2006 47 : 557 62.
8. Elmarakby AA, Williams JM, Imig JD, Pollock JS, Pollock DM. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension. Vasc. Pharmacol. 2007 46 : 44 51.
9. Manhiani MM, Quigley JE, Socha MJ, Motamed K, Imig JD. IL6 suppression provides renal protection independent of blood pressure in a murine model of salt-sensitive hypertension. Kidney Blood Press. Res. 2007 30 : 195 202. (Pubitemid 47076216)
10. Guo M, Ricardo SD, Deane JA, Shi M, Cullen-McEwen L, Bertram JF. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J. Anat. 2005 207 : 813 21.
11. Koya D, Haneda M, Nakagawa H et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J. 2000 14 : 439 47.
12. Chrostowska M, Szczech R, Narkiewicz K. Antihypertensive therapy in the obese hypertensive patient. Curr. Opin. Nephrol. Hypertens. 2006 15 : 487 92.
13. Elmarakby AA, Morsing P, Pollock JS, Pollock DM. Omapatrilat increases renal endothelin in deoxycorticosterone acetate-salt hypertensive rats. Vasc. Pharmacol. 2003 40 : 253 9.
14. Davy KP, Hall JE. Obesity and hypertension: Two epidemics or one? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004 286 : R803 13.
15. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS. Role of leptin in fat regulation. Nature 1996 380 : 677. (Pubitemid 26126093)
16. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 1997 100 : 270 8.
17. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension 1998 31 : 409 14.
18. Ogawa Y, Masuzaki H, Aizawa M et al. Blood pressure elevation in transgenic mice over-expressing leptin, the obese gene product. J. Hypertens. 1998 16 : S7 (Abstract).
19. Koletsky RJ, Ernsberger P. Phenotypic characterization of a genetically obese and hypertensive rat. Rat Genome 1996 2 : 10 22.
20. Rosmond R, Chagnon YC. Hypertension in obesity and the leptin receptor gene locus. J. Clin. Endocrinol. Metab. 2000 85 : 3126 31.
21. Kumano S, Matsumoto H, Takatsu Y, Noguchi J, Kitada C, Ohtaki T. Changes in hypothalamic expression levels of galanin-like peptide in rat and mouse models support that it is a leptin-target peptide. Endocrinology 2003 144 : 2634 43.
22. Tian N, Moore RS, Braddy S et al. Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am. J. Physiol. Heart Circ. Physiol. 2007 293 : H3388 95.
23. Chandramohan G, Bai Y, Norris K, Rodriguez-Iturbe B, Vaziri ND. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys. Am. J. Nephrol. 2008 28 : 158 67.
24. Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008 294 : R76 83.